Nasal spray could tame tough asthma in new trial
Disease control
Not yet recruiting
This study tests an experimental nasal spray called AD17002 in 126 adults with moderate to severe eosinophilic asthma that is not well controlled by current treatments. The spray aims to calm airway inflammation and reduce asthma attacks by boosting the body's natural immune bala…
Phase: PHASE2 • Sponsor: Advagene Biopharma Co. Ltd. • Aim: Disease control
Last updated May 13, 2026 15:58 UTC